Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1

Fig. 6

PD-L1 prevalence in tumour tissue of ovarian cancer patients. Immunohistochemistry (IHC) tissue staining of PD-L1 on tumour cells (TC) and tumour-infiltrating inflammatory/immune cells (IC) (n = 29). a Representative images (×10 magnification) showing PD-L1 IHC on tumour cells (TC) and tumour-infiltrating immune/inflammatory cells (IC); TC/IC1 (low expression); TC/IC2 (medium expression); TC/IC3 (high expression). b PD-L1+TC and PD-L1+IC expression in tissue samples. PD-L1+TC in OC tissue based on c stage, d grade, e Kurman–Shih type and f histologic type of tumours. PD-L1+ IC in tissue samples based on g stage, h grade, i Kurman–Shih type and j histologic type of tumours

Back to article page